Physician profile
Gregory S Anderson
NPI 1992797492
$1,617,055.34
in general payments reported to CMS, 2019-2025
14 companies · $193K in 2025
The $193K reported for 2025 was more than what 99% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $251K · 2020: $200K · 2021: $231K · 2022: $237K · 2023: $255K · 2024: $250K · 2025: $193K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $689K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,331 · Travel and Lodging: $3,405 · Food and Beverage: $432 · Long Term Medical Supply Or Device Loan: $419 · Education: $135.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $689,389.97 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,331.25 |
| Travel and Lodging | $3,404.64 |
| Food and Beverage | $431.72 |
| Long Term Medical Supply Or Device Loan | $418.54 |
| Education | $135.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,181,744.38 | 2020-2025 | Phalinx, Prophecy |
| Wright Medical Technology, INC. | $401,509.38 | 2019-2020 | |
| Heron Therapeutics, INC. | $30,585.71 | 2021-2023 | Zynrelef |
| Treace Medical Concepts, INC. | $1,924.78 | 2021-2025 | |
| Anika Therapeutics, INC. | $529.97 | 2022-2024 | Integrity, Revomotion, Ovo Motion |
| Integra Lifesciences Corporation | $468.10 | 2021-2025 | Acell, Integra, Integra Dermal Regeneration Template |
| Medshape, INC. | $58.02 | 2020 | |
| Biotronik Nro, INC. | $57.66 | 2025 | Prospera |
| Medtronic, INC. | $53.43 | 2023-2024 | Intellis Adaptivestim |
| Trilliant Surgical LLC. | $41.22 | 2019 | |
| Fusion Orthopedics USA, LLC | $31.50 | 2024 | |
| Biocomposites INC | $21.74 | 2025 | Stimulan |
| Mimedx Group, INC. | $16.96 | 2025 | |
| Nevro Corp. | $12.49 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Anderson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.